ABCELLERA BIOLOGICS INC's ticker is ABCL and the CUSIP is 00288U106. A total of 115 filers reported holding ABCELLERA BIOLOGICS INC in Q2 2021. The put-call ratio across all filers is 0.62 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,386 | -27.1% | 214,557 | -14.9% | 0.01% | -31.2% |
| Q1 2023 | $1,902 | +4.1% | 252,192 | +39.8% | 0.02% | -40.7% |
| Q4 2022 | $1,827 | -99.9% | 180,350 | +3.2% | 0.03% | +17.4% |
| Q3 2022 | $1,728,000 | -38.2% | 174,750 | -33.4% | 0.02% | -32.4% |
| Q2 2022 | $2,796,000 | +122.6% | 262,503 | +103.7% | 0.03% | +112.5% |
| Q1 2022 | $1,256,000 | +6.1% | 128,851 | +55.6% | 0.02% | +33.3% |
| Q4 2021 | $1,184,000 | +79.7% | 82,825 | +176.3% | 0.01% | +71.4% |
| Q2 2021 | $659,000 | +109.9% | 29,972 | +224.3% | 0.01% | +40.0% |
| Q1 2021 | $314,000 | -73.0% | 9,243 | -68.0% | 0.01% | -54.5% |
| Q4 2020 | $1,161,000 | – | 28,850 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Founders Fund VII Management, LLC | 3,773,530 | $75,584,000 | 86.10% |
| Gruss & Co., LLC | 430,407 | $8,625,000 | 24.12% |
| SB Management Ltd | 9,817,190 | $196,736,000 | 20.16% |
| GUARDIAN CAPITAL ADVISORS LP | 3,836,414 | $76,767,000 | 7.97% |
| Intellectus Partners, LLC | 1,223,429 | $24,518,000 | 5.93% |
| HARVARD MANAGEMENT CO INC | 4,105,095 | $82,266,000 | 4.82% |
| ArchPoint Investors | 461,289 | $9,244,000 | 2.77% |
| Belmont Capital, LLC | 150,000 | $3,006,000 | 2.44% |
| CLOUGH CAPITAL PARTNERS L P | 971,297 | $19,465,000 | 1.18% |
| Orbimed Advisors | 4,180,768 | $83,783,000 | 0.92% |